The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion.
about
G Protein-Coupled Receptors in CancerNovel Insights into the Roles of Rho Kinase in CancerInteraction between circulating cancer cells and platelets: clinical implicationThe malignancy of metastatic ovarian cancer cells is increased on soft matrices through a mechanosensitive Rho-ROCK pathway.Migrastatics-Anti-metastatic and Anti-invasion Drugs: Promises and Challenges.Oncogenic K-Ras and loss of Smad4 mediate invasion by activating an EGFR/NF-κB Axis that induces expression of MMP9 and uPA in human pancreas progenitor cells.Podoplanin promotes the invasion of oral squamous cell carcinoma in coordination with MT1-MMP and Rho GTPases.ROCK inhibitor Y-27632 inhibits the growth, migration, and invasion of Tca8113 and CAL-27 cells in tongue squamous cell carcinoma.Breast cancer metastasis suppressor 1 (BRMS1) attenuates TGF-β1-induced breast cancer cell aggressiveness through downregulating HIF-1α expression.Aberrant lipid metabolism: an emerging diagnostic and therapeutic target in ovarian cancer.DLC1-dependent parathyroid hormone-like hormone inhibition suppresses breast cancer bone metastasis.Resveratrol suppresses breast cancer cell invasion by inactivating a RhoA/YAP signaling axis.Small Rho GTPases in the control of cell shape and mobility.Diverse effects of LPA receptors on cell motile activities of cancer cells.Promising pharmacological directions in the world of lysophosphatidic Acid signaling.TNF causes changes in glomerular endothelial permeability and morphology through a Rho and myosin light chain kinase-dependent mechanism.Lysophosphatidic Acid Promotes Epithelial to Mesenchymal Transition in Ovarian Cancer Cells by Repressing SIRT1.Gene regulatory networking reveals the molecular cue to lysophosphatidic acid-induced metabolic adaptations in ovarian cancer cellsResveratrol attenuates norepinephrine-induced ovarian cancer invasiveness through downregulating hTERT expression.RhoA and Rac1 play independent roles in lysophosphatidic acid-induced ovarian cancer chemotaxis.A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.Lysophosphatidic acid stimulates activation of focal adhesion kinase and paxillin and promotes cell motility, via LPA1-3, in human pancreatic cancer.Optimization of novel nipecotic bis(amide) inhibitors of the Rho/MKL1/SRF transcriptional pathway as potential anti-metastasis agents.DLC1 induces expression of E-cadherin in prostate cancer cells through Rho pathway and suppresses invasion.EGFR mediates LPA-induced proteolytic enzyme expression and ovarian cancer invasion: inhibition by resveratrolRCP induces Slug expression and cancer cell invasion by stabilizing β1 integrin.Aberrant lipid metabolism in cancer cells - the role of oncolipid-activated signaling.Rab25 augments cancer cell invasiveness through a β1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin.Identification and functional analyses of differentially expressed metabolites in early stage endometrial carcinoma.RCP induces FAK phosphorylation and ovarian cancer cell invasion with inhibition by curcumin.hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressiveness.ROCK inhibitor enhances the growth and migration of BRAF-mutant skin melanoma cells
P2860
Q26741203-FFCCEBB4-2F73-489E-9C05-843A45CBA8F4Q26771368-08D6D9F0-1636-40C2-ADFB-D1BB226ED88DQ26778920-13A2D0B4-ADDC-49DD-BFBC-10953CFF9B56Q33757334-94EDB3A3-E6B5-4609-BDC8-94171312C5C0Q33828559-EB0B6671-A92C-4B64-8E66-DE429A624BCCQ35067751-A60C0415-FED4-49E3-9914-1A4C2A5E1565Q35402652-0F7370EB-D456-4CC3-8F18-88AECD2B65C7Q35807790-42F2844A-789B-4EC6-9C82-BCC713613B0BQ35828437-6C40E098-0FA3-4613-9C9F-8034C78C9AD8Q36820509-E7178851-2855-4301-B28B-44B4FA93ECFEQ37679939-AEE748F8-9856-4DF3-8775-67293A520A3FQ37680062-617445D0-53E2-43F5-B133-4391D7A37959Q38166254-2DB575EC-E9C9-4ECF-8930-3531F44C2124Q38181530-DDF4D330-E618-49DC-925D-572328AA91AEQ38320338-0FF9D0F1-8A70-4892-9EC3-594C8197B5DAQ38565474-2924D524-0F51-4BCA-BF33-0A4BF9D3338FQ38715858-98FAFAFE-3C35-4372-87D4-0A4A35EA39F7Q38753397-2B8CED56-E3EA-4BF6-BB71-38A62B03F595Q38830900-95BEF111-3F28-45D4-BBFB-D44CBC102405Q39029939-D7704E95-86B1-4C7D-9BF2-9698F1E9DF78Q39033598-1742F5B5-B372-40FB-84DB-C17167C27E5BQ39092647-E838F6E1-DCCF-42C0-B19E-5B98FC9A6E26Q39147635-CA27710A-45EF-48CB-A495-63826527E71BQ39200334-C74874A1-58A6-40FB-9CD8-A64BA61C3689Q39249383-467FAD49-16A9-456A-95F3-B5D0B0F0DE58Q40576140-7CE166D3-B261-4B56-899D-8598618A1560Q47710637-0ACBBE9A-BB20-462D-88F4-71D1B183E59FQ49679541-05DE23D1-2C16-4DBA-A284-7EBE39053FA0Q50049923-8A018412-9F47-4523-B0AB-AB2E316DF799Q52560215-DC3B8842-9C86-4F02-816B-41C2412F978BQ53263421-5C1FFD9F-188A-4144-982B-2F9AB5367A83Q58701695-A09576DC-4599-4B93-9147-251EBF101DD2
P2860
The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The Rho/ROCK pathway for lysop ...... ovarian cancer cell invasion.
@en
The Rho/ROCK pathway for lysop ...... ovarian cancer cell invasion.
@nl
type
label
The Rho/ROCK pathway for lysop ...... ovarian cancer cell invasion.
@en
The Rho/ROCK pathway for lysop ...... ovarian cancer cell invasion.
@nl
prefLabel
The Rho/ROCK pathway for lysop ...... ovarian cancer cell invasion.
@en
The Rho/ROCK pathway for lysop ...... ovarian cancer cell invasion.
@nl
P2093
P2860
P356
P1433
P1476
The Rho/ROCK pathway for lysop ...... d ovarian cancer cell invasion
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2011.595
P407
P50
P577
2012-01-16T00:00:00Z